Effect of Fostair® on biomarkers of platelet adhesion in Idiopathic pulmonary fibrosis
A Randomized, Double-blind, Placebo-controlled, Crossover Study toAssess the Effect of 28 Day Treatment with Fostair® pMDI 200/12 on biomarkers of platelet adhesion in Patients with Idiopathic pulmonary fibrosis. - Effect of Fostair® pMDI on biomarkers of platelet adhesion in IPF A Randomized, Double-blind, Placebo-controlled, Crossover Study toAssess the Effect of 28 Day Treatm ...